Kings Research today announced the release of its latest market intelligence study, “Global Real Time Polymerase Chain Reaction Systems Market: Size, Share, Trends & Forecast 2023–2030.” The report provides an in-depth analysis of market size, growth drivers, technological trends, regional outlook, and competitive dynamics.
According to Kings Research, the global real time polymerase chain reaction systems market was valued at USD 4.93 billion in 2022 and is projected to reach USD 7.01 billion by 2030, expanding at a CAGR of 4.57% during the forecast period.
Market growth is being driven by the increasing adoption of real-time PCR in life sciences research, drug development, pathogen detection, and clinical diagnostics. Rising government initiatives supporting precision medicine and high-throughput testing, alongside growing investments by key players, are further accelerating market expansion.
Real-time PCR systems enable accurate, sensitive, and quantitative detection of nucleic acids in real time, offering rapid results compared to traditional culture-based methods. Technological innovations such as digital PCR (dPCR), automated high-throughput platforms, and AI-assisted analysis are enhancing data accuracy, reducing turnaround times, and supporting large-scale testing for infectious diseases and genetic research.
Kings Research identifies the following drivers for the RT-PCR systems market
- Increasing Demand for Infectious Disease Diagnostics: Real-time PCR systems provide rapid, accurate detection of pathogens such as SARS-CoV-2, HIV, and influenza. According to the World Health Organization (WHO), as of 2024, approximately 40.8 million people were living with HIV worldwide, highlighting the critical role of PCR diagnostics in public health. (Source: who.int)
- Advancements in Genomics and Precision Medicine: Growing use of PCR for genetic testing, oncology research, and pharmacogenomics is driving demand.
- High-Throughput and Automated Systems Adoption: Laboratories and clinical facilities are increasingly adopting automated qPCR and dPCR platforms to handle large sample volumes efficiently. This trend is supported by government-funded research programs and clinical trial expansions in North America and Europe.
- Rising Prevalence of Chronic Diseases: Cancer, genetic disorders, and infectious diseases are fueling the adoption of sensitive and quantitative diagnostic technologies. Regulatory compliance with CLIA, HIPAA, and European IVD regulations is further accelerating the deployment of PCR systems.
B2B Leaders in clinical diagnostics, pharmaceutical research, and healthcare laboratories can benefit from RT-PCR systems through
- Rapid and Accurate Results: Real-time PCR enables faster pathogen detection and gene expression analysis.
- Scalability and Efficiency: High-throughput systems allow simultaneous testing of large sample volumes with minimal manual intervention.
- Regulatory Compliance: RT-PCR systems support adherence to global diagnostic standards and reporting guidelines.
Regional Outlook
- North America: Held 43.2% of the market in 2022 (USD 2.13 billion), driven by high adoption in clinical laboratories, strong R&D investments, and widespread use in infectious disease testing.
- Europe: Growing adoption in research centers and hospitals, supported by government funding for genomic studies and clinical trials.
- Asia Pacific: Projected as the fastest-growing region with a CAGR of 5.25%, driven by COVID-19 testing initiatives, increasing adoption of digital PCR technologies, and growing demand for reliable nucleic acid quantification in research and diagnostics.
Competitive Landscape
The RT-PCR systems market is fragmented, with key players focusing on partnerships, mergers & acquisitions, product innovations, and R&D to expand capabilities. Prominent companies include Abbott, Agilent Technologies Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., and Danaher Corporation.
The full Kings Research report offers detailed segmentation by type, product, application, and region, along with competitive benchmarking and industry forecasts. To request a sample report or access the complete study, visit https://www.kingsresearch.com/real-time-polymerase-chain-reaction-systems-market-81.
About Kings Research
Kings Research is a global provider of syndicated research reports and consulting services, enabling organizations to navigate emerging markets, assess opportunities, and make informed strategic decisions.
All market data are sourced from Kings Research proprietary analysis, validated against credible sources and industry publications. Key references include the U.S. Department of Health & Human Services (www.hhs.gov), National Institutes of Health (www.nih.gov), and World Health Organization (www.who.int).